Background. Multiple international treatment guidelines recommend amphotericin-based
combination regimens for induction therapy of cryptococcal meningitis. Yet, only 1 trial has …

Background The purpose of this systematic review is to provide updated evidence on the
preferred induction therapy for the treatment of HIV‐associated cryptococcal meningitis …

Cryptococcal meningitis (CM) is the most fatal adult meningitis in patients with human
immunodeficiency virus (HIV). There is no conclusive evidence for the superiority of 1-week …

Emerging concepts in HIV-associated cryptococcal meningitis : Current Opinion in Infectious
Diseases Emerging concepts in HIV-associated cryptococcal meningitis : Current Opinion in …

Aims Our object was to find the most appropriate, most effective, and most readily available
of four induction regimens for HIV-associated cryptococcal meningitis (CM)(Regimen A: 1 …

Abstract Treatment guidelines recommend combination antifungal therapy with amphotericin
B (AmB) as an induction therapy for cryptococcal meningitis. The objective of this study was …

Purpose of review HIV-associated cryptococcal meningitis remains a significant public
health problem in parts of Africa and Asia and a major cause of AIDS-related mortality …

Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …

Background Cryptococcal meningitis is a severe fungal infection that occurs primarily in the
setting of advanced immunodeficiency and remains a major cause of HIV‐related deaths …

Cryptococcal meningitis is the leading cause of adult meningitis in patients with HIV, and
accounts for 15% of all HIV-related deaths in sub-Saharan Africa. The mainstay of …